Saturday, 10th November Asia Pacific Neuroendocrine Tumour Society 2018

• Challenges of pre-operative and intraoperative management - Bernhard Riedel
• Surgical management - Harjit Singh
• Liver-directed PRRT and therapy - Kumar Kallur
• Endoscopic treatment procedures - Dermot O'Toole
• Pancreatic Neuro-endocrine tumors: Exploring the role of surgical management - Niharika Garach

• Neuroendocrine neoplasm trends over 32 years in Queensland, Australia - David Wyld
• The impact of SSTR2 expression in patients with metastatic GEP-NETs receiving somatostatin analogs - Young Suk Park
• Nutritional status and considerations for patients diagnosed with a gastroenteropancreatic neuroendocrine tumour: preliminary baseline characteristics from the Nutrition in NETs study - Erin Kennedy
• Living with a rare and complex cancer diagnosis: Describing the experiences, information and supportive care needs needs, psychosocial status and characteristics of patients with newly diagnosed Neuroendocrine Tumours - Lisa Guccione
• Peptide receptor radionuclide therapy (PRRT), a promising therapy in adrenocorticotropic hormone (ACTH) producing metastatic neuroendocrine tumour (NET). - Te-Jui (Terry) Hung
• Virilising Adrenal Tumor in 20 yrs Hirsute Female - A Case Report - Sharmin Reza
• A new era in the optimal planning of treatment and research of Neuroendocrine tumours (NETs) in Australia: the PLANET registry  - Simone Leyden
• How often can we make a pre-operative diagnosis of Gastroenteropancreatic NET? Single surgeon series - Subba Rao Mr Kanchustambam
• Atypical presentation of ectopic ACTH/gastrin secretion in an atypical lung carcinoid patient - Cherie Chiang
• A case highlighting the value of ⁶⁸Ga-dotatate PET/CT in the diagnostic dilemma of post-prandial hyperinsulinaemic hypoglycaemia.  - Anna K Mossman
• Renal function influences renal absorbed dosimetry, haematologic toxicity and early withdrawal from 177Lu-DOTATATE treatment   - Nadya Kisiel
• Neuroendocrine neoplasms in the paediatric adolescent and young adult population in New Zealand and Queensland Australia - David Wyld

• Carcinoid heart disease - medical management - Simona Glasberg
• Carcinoid heart disease - surgical management  - Marco Larobina
• Challenging cases presentation - Te-Jui (Terry) Hung
• Takotsubo cardiomyopathy – a case report in a patient with metastatic phaeochromocytoma receiving steroids with Peptide Receptor Radionuclide Therapy (PRRT) - Marni Nenke

• New concepts in NEN pathology  - Anita Borges
• Challenges and Treatment options for patients with Grade 3 GEP NEN ‘Medical Management + PRRT - Halfdan Sorbye
• Peptide receptor radionuclide therapy (PRRT) in ENETS Grade 3 (G3) Neuroendocrine Neoplasia (NEN) - a single-institution retrospective analysis - Mei Sim Lung
• Identification and characterization of novel markers in high grade neuroendocrine tumor cells - Abhirami Venugopal

Afternoon Tea and Poster Session 2 – Even Numbers
2:40PM - 3:20PM                                                                                                                 Eureka Rooms 2 & 3

• A case of appendiceal goblet cell carcinoid tumour - Waye Hann Kang
• Retrospective analysis of systemic chemotherapy for poorly differentiated extra-pulmonary neuroendocrine carcinoma - Woo Kyun Bae
• AGITG NABNEC:  A Randomised Phase II Study of Nab-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas - Lorraine Chantrill
• Exploring nutrition screening and management practices amongst health professionals managing patients with neuroendocrine tumours - Erin Kennedy
• Renal tubular injury presenting after 177Lu-DOTATATE peptide receptor radionuclide therapy with high renal dosimetry - David Pattison
• A 41 year old patient with abdominal sepsis from neuroendocrine tumour misdiagnosed as pelvic inflammatory disease - David Becker
• Punching above its weight - The Australasian Merkel Cell Carcinoma Patient Advocacy Group - Katrina Diamante
• Adrenocortical carcinoma presenting with combined hypersecretion of adrenal steroid hormones. - Elizabeth George
• Hemosuccus Entericus Is It NET? - Subba Rao Kanchustambam
• Ectopic Acromegaly due to GHRH-secreting Bronchial Tumour - Christopher Yates
• Impact of [68Ga]-DOTATATE PET after resection of appendiceal NEN: A retrospective study - Dale L Bailey
• Comparability of ⁶⁷Cu-SARTATE and ¹⁷⁷Lu-DOTA-octreotate efficacy in a preclinical model of neuroendocrine tumour - Amos Hedt
• Staged IVC venous sampling for ACTH in a Von-Hippel-Lindau syndrome (VHL) patient with Cushing's syndrome, pancreatic neuroendocrine tumor and renal cell carcinoma - Amalina Dr Haydar Ali Tajuddin

• Challenges and management of NETs from other origins ‘ Pulmonary NET, Unknown primary - Halfdan Sorbye
• PPGL - imaging and theranostics  - Simona Glasberg
• Genomics and immunogenomics of Merkel Cell Carcinoma  - Richard Tothill
• Overview, management and novel treatment approaches to Merkel Cell Carcinoma - Shahneen Sandhu
• Biliary Mixed Neuroendocrine-Nonneuroendocrine Neoplasms: a series of four cases with review of literature - Niharika Garach
• Clinical, Genetic, and Molecular Characterizations of Pheochromocytoma in MEN2 - Rami Alrezk